Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic DNA in the tumor microenvironment refers to fragments of nuclear and mitochondrial DNA released from tumor cells undergoing necrosis. This DNA acts as a damage-associated molecular pattern (DAMP), triggering innate immune responses and influencing the tumor microenvironment. While it can initially promote anti-tumor immunity, persistent exposure often leads to chronic inflammation and tumor progression by supporting angiogenesis, stromal remodeling, and recruitment of immunosuppressive cells.
Targeting DAMP signaling pathways (e.g., STING activation) may modulate immune responses against tumors. Understanding how released nucleic acids shape the microenvironment could inform strategies for immunotherapy or combination treatments targeting both cell death mechanisms and downstream inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic DNA (N/A).